Skip to main content
Caplight Logo









Amai Proteins

Amai Proteins

Private
IsraelFrontier & Industrial Techhttps://amaiproteins.com

Last Round

Series A

Jan 10, 2023

Total Funding Raised

$135.75M

Company Overview

Amai Proteins operates in Frontier & Industrial Tech and is based in Israel. Its latest recorded funding round was a Series A round in January 2023.

Amai Proteins is a food technology company that develops novel designer proteins, including its flagship hyper-sweet protein sweelin™, to help the food and beverage industry reduce sugar content.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Amai Proteins Comparables

Compare Amai Proteins with similar companies based on industry and business-model similarity.

Amai Proteins comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Incredo
83%
Oobli
82%
Naturannova
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Amai Proteins Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 10, 2023
Series ADec 2, 2022
Series ASep 6, 2021
SeedApr 1, 2020
SeedApr 11, 2019
Convertible Debt
Feb 1, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Moshe Hukaylo

Chief Financial Officer

Executive Team

Yigal Gezundhait

Chief Production Officer, COO

Executive Team

For institutional investors. Book with your work email.

Amai Proteins Investors

Notable investors and investment history

Amai Proteins investors
InvestorRounds
Geshem PartnersSeries A
Israel Innovation AuthorityConvertible Debt, Seed
Sucden VenturesSeries A
Harrison Co.Series A
Israel Innovation AuthoritySeed
Danone Manifesto VenturesSeries A
Welltech VenturesSeed, Series A
Book a demo to see all 19 investors

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 2, 2022

    $100M round led by Conquest Global Ventures VCC.

  • Sep 6, 2021

    $11.3M round with participation from SGInnovate and Dragones Venture Partners.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • hiresSep 15, 2026

    On Sep 15th '26 in Israel, Amai Proteins transitions Amir Guttman, who serves as CEO from July 2025, to an executive board member role.

  • hiresSep 10, 2026

    Amai Proteins appoints Doug Brown as CEO effective Sep 1st '26 to lead the commercial scale-up of its sweelin(R) sweet protein in Israel.

Book a demo to see all news

For institutional investors. Book with your work email.

Amai Proteins Filings

Explore SEC and related filing metadata, where available.

Amai Proteins filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Amai Proteins's valuation, stock price, and market status.

Is Amai Proteins a public or private company?

Amai Proteins is a private company.

What is the current stock price of Amai Proteins?

Amai Proteins is a private company, so its shares have no public market price. Caplight tracks Amai Proteins's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Amai Proteins worth (valuation)?

Valuation information for Amai Proteins is not publicly available.

Can I buy Amai Proteins stock?

Amai Proteins shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Amai Proteins's last funding round?

Amai Proteins's most recent funding round was Series A on January 10, 2023.

Who are the main investors in Amai Proteins?

Key investors in Amai Proteins include Israel Innovation Authority, Conquest Global Ventures VCC, The Kitchen FoodTech Hub.

Will Amai Proteins IPO soon?

No public IPO plans have been announced for Amai Proteins.

How can I track Amai Proteins secondary market activity?

Caplight tracks bids, offers, and trades in Amai Proteins's shares on secondary markets.

Firmographic Details

HeadquartersIsrael
Employee Range45
Year Founded2016
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?